These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4985431)

  • 41. Assay of arbovirus neutralizing antibody by micro methods.
    Sukhavachana P; Yuill TM; Russell PK
    Trans R Soc Trop Med Hyg; 1969; 63(4):446-55. PubMed ID: 4309633
    [No Abstract]   [Full Text] [Related]  

  • 42. Preparation and evaluation of a noninfectious monkey pox virus vaccine.
    Olsen RG; Blakeslee JR; Mathes L; Nakano JH
    J Clin Microbiol; 1977 Jul; 6(1):50-4. PubMed ID: 195980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice.
    Arévalo MT; Huang Y; Jones CA; Ross TM
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007316. PubMed ID: 31026260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys.
    Putnak R; Barvir DA; Burrous JM; Dubois DR; D'Andrea VM; Hoke CH; Sadoff JC; Eckels KH
    J Infect Dis; 1996 Dec; 174(6):1176-84. PubMed ID: 8940206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation.
    Pawar SD; Murtadak VB; Kale SD; Shinde PV; Parkhi SS
    J Virol Methods; 2015 Sep; 222():28-33. PubMed ID: 25997377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of the complement-fixing antigen of equine infectious anemia virus.
    Kono Y
    Natl Inst Anim Health Q (Tokyo); 1968; 8(3):117-21. PubMed ID: 4305805
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study of anti-Chikungunya antibodies in Vietnamese children in Saigon].
    Vu-Qui-Dai ; Nguyen-Thi Kim-Thoa ; Ly-Quoc-Bang
    Bull Soc Pathol Exot Filiales; 1967; 60(14):353-9. PubMed ID: 5632304
    [No Abstract]   [Full Text] [Related]  

  • 48. A chikungunya fever vaccine utilizing an insect-specific virus platform.
    Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
    Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect Cells.
    Metz SW; Pijlman GP
    Methods Mol Biol; 2016; 1426():297-309. PubMed ID: 27233282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
    Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
    Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on reovirus-antigens. II. Segregation of reovirus-antigens by chromatography on ecteola-cellulose and by centrifugation in a sucrose density gradient.
    Bruggeman CA; Versteeg J
    Arch Gesamte Virusforsch; 1973; 42(4):378-87. PubMed ID: 4203175
    [No Abstract]   [Full Text] [Related]  

  • 52. A salt-dependent hemagglutinating particle from measles-infected cells.
    Schluederberg A; Nakamura M
    Virology; 1967 Oct; 33(2):297-306. PubMed ID: 4964685
    [No Abstract]   [Full Text] [Related]  

  • 53. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid preparation of hemagglutinins of togaviruses from infected cell culture fluids.
    Della-Porta AJ; Westaway EG
    Appl Microbiol; 1972 Jan; 23(1):158-60. PubMed ID: 4621791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural constituents of Venezuelan equine encephalitis virus.
    Horzinek M; Munz K
    Arch Gesamte Virusforsch; 1969; 27(1):94-108. PubMed ID: 4981664
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of an attenuated strain of chikungunya virus for use in vaccine production.
    Levitt NH; Ramsburg HH; Hasty SE; Repik PM; Cole FE; Lupton HW
    Vaccine; 1986 Sep; 4(3):157-62. PubMed ID: 3020820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small size rubella virus antigens and soluble immune complexes: analysis by the platelet aggregation technique.
    Vaheri A; Vesikari T
    Arch Gesamte Virusforsch; 1971; 35(1):10-24. PubMed ID: 5002146
    [No Abstract]   [Full Text] [Related]  

  • 59. Isolation of chikungunya virus contaminating an Aedes albopictus cell line.
    Cunningham A; Buckley SM; Casals J; Webb SR
    J Gen Virol; 1975 Apr; 27(1):97-100. PubMed ID: 806659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody against Chikungunya virus in wild primates in Southern Africa.
    McIntosh BM
    S Afr J Med Sci; 1970 Dec; 35(3):65-74. PubMed ID: 4398581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.